This week AZBio will be in Washington, D.C. meeting with our Arizona Congressional Delegation and thanking them for their work and support in permanently repealing the Medical Device Excise Tax. AZBio will be joining medtech leaders from across the country as part of the annual AdvaMed Fly-In. Even if you are not able to be with us LIVE in Washington, D.C. you can share your thanks with your Representative and Senators electronically by clicking here. Continue reading
Category Archives: Blogs
AZBio Blogs
Calling on Congress to Repeal The Medical Device Excise Tax
On September 24, 2019, a letter was sent to Congressional Leaders in the Senate and House leadership on behalf of a group of over six hundred innovators, patient groups, physicians, hospitals, venture capitalists and other stakeholders representing millions of patients and hundreds of thousands medical technology jobs, requesting that Congress prioritize repeal of the medical device excise tax before it causes any more harm to the innovation ecosystem. Continue reading
Announcing the 2017 AZBio Trailblazers
The 2017 AZBio Trailblazer Honorees are: House Speaker JD Mesnard, Senator Nancy Barto, Senator Kimberly Yee, Senator Kate Brophy McGee, Representative Lela Alston, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, and Representative Jay Lawrence.Continue reading
Congresswoman Sinema Honored as BIO Legislator of the Year
Washington, D.C. (April 5, 2017) – The Biotechnology Innovation Organization (BIO) announced today its selection of Congresswoman Kyrsten Sinema (D-AZ) as a 2017 Legislator of the Year. Congresswoman Sinema will receive the award in conjunction with BIO’s Legislative Day Fly-In.
Sharing Arizona Bioindustry News in Washington DC
AZBio delivered data on life-changing innovation and the economic impact of Arizona’s life sciences industry to Arizona’s Congressional Delegation last week in meetings with 10 of Arizona’s 11 Congressional offices.
Understanding Gov. Ducey’s $1 billion university research infrastructure plan
Building on Success for a Better Arizona – Your Letter Can Make a Difference – Click Here to Learn More
Bill to Streamline CMS’s Process for Breakthrough Technologies Introduced in the US Senate
The Ensuring Patient Access to Critical Breakthrough Products Act, will help bridge a gap between FDA and CMS and improve patient access to breakthrough medical technologies for serious illnesses, S. 2998, to expedite CMS decision-making for innovative medical technologies.Continue reading
AZBio Watch List- The Final Tally
The Arizona Legislature has adjourned Sine Die as of May 7th, 2016 5:45 A.M.
Here is the final tally for the 2016 Legislative SessionContinue reading
AZBio Watch List as of May 15th
The Arizona Legislature has adjourned Sine Die as of May 7th, 2016 5:45 A.M.
The General Effective date will be August 6th, 2016 unless otherwise stated in the bill text.Continue reading
Life Science Leaders Comment on Medicare Part B Drug Payment Proposed Rule
The Arizona Bioindustry Association (AZBio) together with 42 other state bioindustry associations submited comments to the Centers for Medicare & Medicaid Services’ (CMS’s) Center for Medicare and Medicaid Innovation (CMMI) Medicare Part B Drug Payment Proposed Rule, released March 8, 2016.Continue reading